Menu

NOAA: Common Pesticides Threaten Endangered Salmon, Other Marine Life

Organophosphates jeopardize dozens of species, a federal review finds.

Jan 16, 2018
Shawna Williams

A coho salmon FLICKR, BUREAU OF LAND MANAGEMENTUse of the organophosphate pesticides chlorpyrifos, diazinon, and malathion should be restricted to protect marine life, an extensive review by the National Oceanic and Atmospheric Administration’s National Marine Fisheries Service (NOAA Fisheries) concludes. The 3,400-page report was made public last week by the advocacy organization Earthjustice, E&E News reports.

“The best available science clearly shows these pesticides are a major threat to endangered salmon and to our orca whales, which need salmon to survive,” Patti Goldman, managing attorney at Earthjustice, tells E&E News. “These pesticides are bad for people every way they are exposed to it and toxic to salmon.”

The Associated Press notes that environmentalists and commercial fishers have fought in court for decades for more government scrutiny of organophosphates, a class of pesticides derived from a chemical weapon. The new report was completed just prior to a court-imposed end-of-year deadline for NOAA Fisheries to issue its findings.

“The denial of a requested extension of time to complete the opinion resulted in a document that has the potential to create exaggerated and unfounded concerns regarding threatened and endangered species and have a negative impact on farmers as well as public health protection,” Jay Vroom, CEO of industry trade group CropLife America, says in a statement (via E&E News). President Donald Trump’s administration had earlier requested a two-year extension of the 2017 deadline for the report.

But Glen Spain of the Pacific Coast Federation of Fishermen's Associations tells E&E News that “Salmon have been waiting four decades for relief from toxic pesticides in many of our rivers. . . . The agencies should do their job.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.